Delivery Order SPE2DB22D3004-SPE2DB25FPS35

Award Date 2/26/25
Potential Completion Date 3/19/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,578.39, is for the delivery of LORBRENA 100 MG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company. The contract, valued at $10,578.39, is for the delivery of 4564002715 - LORBRENA 100 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LORBRENA 100MG TAB 30S, a pharmaceutical product, with a ceiling value of $22,688.62 and a period of performance through March 19, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $10,965.33, is for the delivery of 4,564,294,649 tablets of the drug Lorbrena (100 mg) to the government. Amerisourcebergen Drug Corp, through its Corporate Office Division, holds a single-award Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide LORBRENA 100 MG TABLET 30S to the Defense Logistics Agency (DLA). The contract has a ceiling value of $11,344.30, a firm fixed price, and a completion date of February 20, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order worth $1,041.93 and has a completion date of June 24, 2024. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $17,056.07 firm fixed-price contract has a completion date of January 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,785.10 firm-fixed-price contract has a completion date of January 31, 2025 and does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $100,519.44 firm-fixed-price contract has a completion date of November 25, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,513.35 firm fixed-price contract has an ultimate completion date of January 13, 2025. Amerisourcebergen is a for-profit organization that specializes in distributing a wide range of pharmaceutical products, medical supplies, and equipment to federal healthcare programs, particularly those serving...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPS35
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,344.30, is for the delivery of Lorbrena 100 mg tablets over a period ending on March 19, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/28/25, 10:49 AM